The ONLY Rheumatology-Focused CRO
STOP THE NOISE!
How to Mitigate Placebo Response in Rheumatology Trials
Save Your Seat
JOIN US FOR A PRIVATE EVENT DURING ACR CONVERGENCE 2026

Dr. Andreas Kerschbaumer
MD, PhD

Stanford University, CA, USA, and Medical University of Vienna

Dr. Joan T. Merrill
MD

Oklahoma Medical
Research Foundation

Dr. Juan Ovalles
MD, PhD

Senior Director,
Rheumatology, Indero

Pina D'Angelo
MSc

Global Head, Data, Medical and Regulatory Sciences, Indero 

Leading KOLs will share their strategies for mitigating placebo response rates in:
Rheumatoid Arthritis (RA)
Psoriatic Arthritis (PsA)
Systemic Lupus Erythematosus (SLE)
Scientific Presentations
Roundtable Discussions
Save Your Seat
Across the street from
ACR Convergence 2026
Monday,
November 9th, 2026
7 am – 9 am
Eastern Time (ET)
Fuel up your body and fire up your mind with breakfast & bottomless
coffee on us at this one-of-a-kind learning opportunity!
Register Now!

*By subscribing to our communications, you acknowledge and agree to the terms of our privacy policy.